July 9 (Reuters) – AstraZeneca said on Thursday that its drug Wainua, made in partnership with Ionis, failed to meet the main goal of reducing cardiovascular deaths and recurring heart problems in a late-stage trial.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Janane Venkatraman)
Comments